Professor Chim Lang
Clinical Professor (Teaching and Research)
Molecular and Clinical Medicine, School of Medicine
+44 (0)1382 383283
Ninewells - Mailbox 2
Professor Lang is a consultant cardiologist and clinical pharmacologist and Professor of Cardiology at Ninewells Hospital and Medical School, Dundee, United Kingdom.
He trained in both cardiology and clinical pharmacology in the United Kingdom and in the United States where he was a Merck International Fellow in Clinical Pharmacology at Vanderbilt University, Nashville and a Fulbright Scholar at Columbia University, New York. He is a Fellow of the Royal Colleges of Physicians of London and Edinburgh and the American College of Cardiology and European Society of Cardiology.
- The eyes have it as Dundee University heads artificial intelligence project - Dundee Courier
- Cheap Drug to defeat heart disease - Express
- Retinal Scans Provide Heart Failure Warning Signals - Labmate
- Diabetic drug shown to reduce the risk of heart disease in non-diabetic patients - EurekAlert
- Drug used to treat type 2 diabetes could also reduce heart disease - Diabetic Research and Wellness Foundation
- Call for ‘less aggressive’ diabetes treatment - Diabetes Times
- Good HbA1c levels could benefit type 2 diabetes patients with chronic heart failure, study finds - Diabetes.co.uk
Professor Lang is a translational cardiologist with a track record of research excellence in the area of cardio-metabolic diseases. He has published >250 papers in major journals, including NEJM, Lancet, European Heart Journal, JACC and Circulation.
His research takes a multi-disciplinary approach to the understanding of the pathophysiology and pharmacogenetics of cardiovascular diseases and to the development of treatment strategies in patients with cardiovascular diseases.
He leads an integrated cardiovascular research laboratory dedicated and equipped to the study of cardiac and vasomotor regulation. These techniques are applied towards translational research and in the development of biomarkers and novel treatment strategies in patients with cardiovascular diseases.
Prof Lang is WP Co-Lead in the €12.3M IMI2-CARDIATEAM project on diabetic cardiomyopathy and was WP lead in the €11.9M FP-7 BIOSTAT system biology project on heart failure and is the Chief Investigator of the BHF funded MET-REMODEL and RECEDE trials and the EFSD funded REFORM trial.
He is also the lead Applicant of the MRC funded MRC UK-Malaysia Partnership on the Precision medicine for diabetic Individuals: a joint Malaysia-UK Effort (PRIME) project.
He is the UK National Coordinator of the multi-international COMMANDER-HF and SELECT trials. A wide range of funding bodies including the British Heart Foundation, MRC, Chief Scientist Office, EASD, Chest Heart and Stroke Scotland, Tenovus and the European commission Seventh Framework (FP-7) and Horizon 2020 Programmes funds his research.
Full contribution to teaching in Dundee, especially cardiology and clinical pharmacology. External undergraduate examinerships (National University of Singapore, University of Malaya, International Medical University, Malaysia, National University of Malaysia). Supervisor of 25 MD/PhDs personally. External examiner for PhD/ MD (Universities of Birmingham, Cardiff, Edinburgh, Glasgow, Aberdeen, Hull)
The Universities of Dundee, Glasgow, Exeter, Birmingham, Cambridge, and York have received £2.4 million to lead a clinical trial of a home-based cardiac rehabilitation programme for people with heart failure and their caregivers.
Professor Chim Lang may be based 7000 miles from his homeland of Malaysia, but he is always surrounded by reminders of home thanks to the Malaysian colleagues that work alongside him in Dundee
The University of Dundee is to bring its expertise in diabetes, precision medicine and machine learning to bear on a project aiming to improve the outcomes for people with diabetes in Malaysia.